Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

HIGHLIGHTS

• who: M. Lefort from the 309, CNRS, Inserm, France Department of Medicine, University of Melbourne, Melbourne, Australia have published the paper: Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis, in the Journal: (JOURNAL)
• what: The aim of this empirical study was to elucidate the impact of methods of causal inference on the results of comparative effectiveness studies. The authors focus on three studies which used data from three multiple_sclerosis (MS) registries, with differences in methods and conclusions . The authors focus on the impact of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.